コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 multiple M. tuberculosis strains (including multidrug-resistant strains).
2 tridium difficile strain 630, a virulent and multidrug-resistant strain.
3 enome-based prediction tools to identify the multidrug-resistant strain.
4 baumannii 5075 (AB5075), a hypervirulent and multidrug-resistant strain.
5 ainst many Gram-positive bacteria, including multidrug resistant strains.
6 be lethal due to the global dissemination of multidrug resistant strains.
7 ferring antibiotic resistance and generating multidrug resistant strains.
8 itis caused by Enterobacteriaceae, including multidrug-resistant strains.
9 losis strains, including clinically isolated multidrug-resistant strains.
10 e antibacterial activities including several multidrug-resistant strains.
11 s of function was observed exclusively among multidrug-resistant strains.
12 azole drugs, resulting in difficult-to-treat multidrug-resistant strains.
13 s steadily increased, with a predominance of multidrug-resistant strains.
14 ing colonization and subsequent infection by multidrug-resistant strains.
15 ome active against pathogenic Clostridia and multidrug-resistant strains.
16 This applies also to multidrug-resistant strains.
17 f outbreaks and aid in the identification of multidrug-resistant strains.
18 ue to the increasingly frequent isolation of multidrug-resistant strains.
19 gnificantly reduced lung pathology, even for multidrug-resistant strains.
20 ombat the increasing burden of infections by multidrug-resistant strains.
21 reat to human health due to the isolation of multidrug-resistant strains.
22 bacter infections, including those caused by multidrug-resistant strains.
23 Gram-positive and Gram-negative bacteria and multidrug-resistant strains.
24 mportance of polymyxins and the emergence of multidrug resistant strains(5), our understanding of the
25 bility to azithromycin (67%) and most of the multidrug-resistant strains (54%); thus, poor clinical o
28 ones, beta-lactam/beta-lactamase inhibitors, multidrug resistant strains and carbapenem-resistant Ent
29 increasingly difficult due to the spread of multidrug resistant strains and thus requires a deeper u
30 hlighting the environment as a reservoir for multidrug-resistant strains and emphasizing the need for
31 l activity against N. gonorrhoeae, including multidrug-resistant strains and key Gram-positive, fasti
33 ated for antiplasmodial activity against K1 (multidrug resistant strain) and NF54 (sensitive strain).
34 is isolates (including both pansensitive and multidrug-resistant strains) and the H37Rv strain by usi
35 gainst Mycobacterium tuberculosis, including multidrug-resistant strains, and some species of nontube
36 pensity to develop antibiotic resistance and multidrug resistant strains are endemic in hospitals.
38 to human health because of the emergence of multidrug-resistant strains associated with hospital out
39 linical isolates of N. gonorrhoeae including multidrug-resistant strains at a concentration as low as
40 fatality ratio, and the common detection of multidrug-resistant strains call for a need to improve t
42 e show that in synchronized PDR1 and pdr1-3 (multidrug resistant) strains, cellular efflux of a known
44 R4 by using whole genomic DNA extracted from multidrug-resistant strain GA71, a serotype 19F variant
45 angerous bioweapon agents, and concern about multidrug-resistant strains has led to the development o
46 Acinetobacter baumannii infection, including multidrug-resistant strains, has inconclusive impact on
47 to therapy, and the increasing frequency of multidrug-resistant strains have necessitated the search
48 tent drug resistance profiles, including six multidrug-resistant strains; however, analysis of ONT da
49 cations of Acinetobacter baumannii including multidrug-resistant strains in patients were compared to
50 ith the majority of each (76% and 88%) being multidrug-resistant strains in three sublineages of the
53 irds and, in one case, identical to a highly multidrug resistant strain isolated from a human child.
54 ding UPEC, and is frequently associated with multidrug-resistant strains, it represents a promising n
55 at to public health due to the prevalence of multidrug-resistant strains, leading the World Health Or
56 compounds possess potent activity against a multidrug resistant strain of P. falciparum and arrest p
57 r antimicrobial drug development as emerging multidrug resistant strains of bacteria become more prev
58 treat most patients, the rapid emergence of multidrug resistant strains of Mycobacterium tuberculosi
59 e and assessed for in vitro activity against multidrug resistant strains of Plasmodium falciparum and
60 s have potent antibacterial activity against multidrug resistant strains of S. aureus, and compound 3
61 al activity against NF54 (sensitive) and K1 (multidrug resistant) strains of the malaria parasite Pla
63 n Thailand have identified a clonal outbreak multidrug-resistant strain of Mycobacterium tuberculosis
67 s previously reported for Shigella, specific multidrug-resistant strains of Campylobacter are circula
68 s previously reported for Shigella, specific multidrug-resistant strains of Campylobacter are circula
69 risons and microbiological data suggest that multidrug-resistant strains of gram-positive cocci emplo
70 Triclosan and its analogs 1 and 2 killed multidrug-resistant strains of intra-erythrocytic P. fal
71 ns are a large proportion of HAI agents, and multidrug-resistant strains of Klebsiella pneumoniae, a
73 (37)Rv and against seven clinically isolated multidrug-resistant strains of M. tuberculosis were foun
74 s consisting of five drug-sensitive and five multidrug-resistant strains of M. tuberculosis, with 6 b
76 ed by the HIV/AIDS pandemic and emergence of multidrug-resistant strains of Mycobacterium tuberculosi
77 creasingly complicated with the emergence of multidrug-resistant strains of Mycobacterium tuberculosi
78 tuberculosis drug, active against a range of multidrug-resistant strains of Mycobacterium tuberculosi
79 ich includes an increase in the isolation of multidrug-resistant strains of Mycobacterium tuberculosi
80 t in antimicrobial activity observed against multidrug-resistant strains of Pseudomonas aeruginosa an
81 ificity efflux pumps have been implicated in multidrug-resistant strains of Pseudomonas aeruginosa an
82 sitive and Gram-negative bacteria, including multidrug-resistant strains of Staphylococcus aureus, Es
83 ar potency against both drug-susceptible and multidrug-resistant strains of the tubercle bacillus.
85 th an isoniazid-resistant (as a surrogate of multidrug-resistant) strain of Mycobacterium tuberculosi
86 ctivity against the 3D7 (sensitive) and Dd2 (multidrug-resistant) strains of Plasmodium falciparum wi
87 its over monotherapy, it may also select for multidrug-resistant strains, particularly during long-te
88 f healthcare-associated infections caused by multidrug-resistant strains producing extended-spectrum
89 ncern, exacerbated by the rapid emergence of multidrug resistant strains refractory to antibiotic tre
90 s, and (ii) because of this incompatibility, multidrug-resistant strains sharing features found in V5
91 nly employed in the clinic and the growth of multidrug resistant strains suggest that the development
92 with single-colony phenotyping to identify a multidrug-resistant strain that had infected a patient f
94 tential against bacteria, including clinical multidrug-resistant strains, that depends critically on
95 s been aggravated by the recent emergence of multidrug-resistant strains, thus stressing the need for
97 and Heligmosomoides polygyrus, as well as a multidrug resistant strain (UGA) of Haemonchus contortus
100 Of particular concern is the emergence of multidrug-resistant strains, which has been rapid among
101 at prolonged patient treatment can result in multidrug-resistant strains with no fitness defect and t